Neuromuscular Blocking Agents: Clinical Trials

2 trials of Neuromuscular Blocking Agents, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting, 1 terminated. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Not yet recruiting 1, Terminated 1

Follow Neuromuscular Blocking Agents: new trials by email Literature Review of Neuromuscular Blocking Agents trials Research Report on Neuromuscular Blocking Agents

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Individualized Positive End-expiratory Pressure Guided by End-expiratory Lung Volume in the Acute Respiratory Distress Syndrome
Invasive Mechanical ventilation, Neuromuscular Blocking Agents, Prone positioning - Respiratory Distress Syndrome, Adult
Phase 3TerminatedFondazione Policlinico Universitario Agostino Gemelli IRCCS182022-11-012025-09-30
Comparison of Sugammadex and Neostigmine During PACU Stay
Neuromuscular Blocking Agents - Neuromuscular Blockade
Phase 3Not yet recruitingUniversity of South Florida502019-10-152019-09-19

Conditions studied

Respiratory Distress Syndrome (1)  ·  Ventilator-Induced Lung Injury (1)

Sponsors

Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1)  ·  University of South Florida (1)

Countries

Italy (1)  ·  United States (1)

Top investigators

Domenico Luca Grieco, MD (1)  ·  Enrico M Camporesi, MD (1)  ·  Maha Balouch, MA (1)  ·  Massimo Antonelli, MD (1)  ·  Michael Albrink, MD (1)

Results publications

PMID 33784416, PMID 35057852